While tumor cells themselves can express checkpoint ligands such as PD-L1 downstream of oncogenic signaling, PD-L1 expression appears to be mainly IFN-responsive within the tumor microenvironment [83,84]. The gene discussed is IFNA1; the disease is neoplasm.